INTRODUCTION: Ultrasound (US)-enhanced thrombolytic treatment protocols currently in clinical trials for stroke applications involve systemic administration of tissue plasminogen activator (tPA; Alteplase), which carries a risk of adverse bleeding events. The present study aimed to compare the thrombolytic efficacy of a tPA-loaded echogenic liposome (ELIP) formulation with insonification protocols causing rapid fragmentation or acoustically-driven diffusion. MATERIALS AND METHODS: Thrombi were induced in the abdominal aortas of male New Zealand white rabbits (2-3kg) using thrombin and a sclerosing agent (sodium ricinoleate) after aortic denudation with a balloon catheter. Thrombolytic and cavitation nucleation agents (200μg of tPA alone, tPA mixed with 50μg of a microbubble contrast agent, or tPA-loaded ELIP) were bolus- injected proximal to the clot through a catheter introduced into the abdominal aorta from the carotid artery. Clots were exposed to transabdominal color Doppler US (6MHz) for 30 minutes at a low mechanical index (MI=0.2) to induce sustained bubble activity (acoustically-driven diffusion), or for 2 minutes at an MI of 0.4 to cause ELIP fragmentation. Degree of recanalization was determined by Doppler flow measurements distal to the clots. RESULTS: All treatments showed thrombolysis, but tPA-loaded ELIP was the most efficacious regimen. Both US treatment strategies enhanced thrombolytic activity over control conditions. CONCLUSIONS: The thrombolytic efficacy of tPA-loaded ELIP is comparable to other clinically described effective treatment protocols, while offering the advantages of US monitoring and enhanced thrombolysis from a site-specific delivery agent.
INTRODUCTION: Ultrasound (US)-enhanced thrombolytic treatment protocols currently in clinical trials for stroke applications involve systemic administration of tissue plasminogen activator (tPA; Alteplase), which carries a risk of adverse bleeding events. The present study aimed to compare the thrombolytic efficacy of a tPA-loaded echogenic liposome (ELIP) formulation with insonification protocols causing rapid fragmentation or acoustically-driven diffusion. MATERIALS AND METHODS:Thrombi were induced in the abdominal aortas of male New Zealand white rabbits (2-3kg) using thrombin and a sclerosing agent (sodium ricinoleate) after aortic denudation with a balloon catheter. Thrombolytic and cavitation nucleation agents (200μg of tPA alone, tPA mixed with 50μg of a microbubble contrast agent, or tPA-loaded ELIP) were bolus- injected proximal to the clot through a catheter introduced into the abdominal aorta from the carotid artery. Clots were exposed to transabdominal color Doppler US (6MHz) for 30 minutes at a low mechanical index (MI=0.2) to induce sustained bubble activity (acoustically-driven diffusion), or for 2 minutes at an MI of 0.4 to cause ELIP fragmentation. Degree of recanalization was determined by Doppler flow measurements distal to the clots. RESULTS: All treatments showed thrombolysis, but tPA-loaded ELIP was the most efficacious regimen. Both US treatment strategies enhanced thrombolytic activity over control conditions. CONCLUSIONS: The thrombolytic efficacy of tPA-loaded ELIP is comparable to other clinically described effective treatment protocols, while offering the advantages of US monitoring and enhanced thrombolysis from a site-specific delivery agent.
Authors: Shaoling Huang; Andrew J Hamilton; Susan D Tiukinhoy; Ashwin Nagaraj; Bonnie J Kane; Melvin Klegerman; David D McPherson; Robert C MacDonald Journal: Cell Mol Biol Lett Date: 2002 Impact factor: 5.787
Authors: S L Huang; A J Hamilton; A Nagaraj; S D Tiukinhoy; M E Klegerman; D D McPherson; R C Macdonald Journal: J Pharm Sci Date: 2001-12 Impact factor: 3.534
Authors: Aliza T Brown; Rene Flores; Eric Hamilton; Paula K Roberson; Michael J Borrelli; William C Culp Journal: Invest Radiol Date: 2011-03 Impact factor: 6.016
Authors: Marc Ribo; Carlos A Molina; Beatriz Alvarez; Marta Rubiera; Jose Alvarez-Sabin; Manel Matas Journal: J Neuroimaging Date: 2009-02-13 Impact factor: 2.486
Authors: Kenneth B Bader; Kevin J Haworth; Himanshu Shekhar; Adam D Maxwell; Tao Peng; David D McPherson; Christy K Holland Journal: Phys Med Biol Date: 2016-06-29 Impact factor: 3.609
Authors: Xi Zhang; Gabe E Owens; Charles A Cain; Hitinder S Gurm; Jonathan Macoskey; Zhen Xu Journal: Ultrasound Med Biol Date: 2016-05-07 Impact factor: 2.998
Authors: Hyunggun Kim; Patrick H Kee; Yonghoon Rim; Melanie R Moody; Melvin E Klegerman; Deborah Vela; Shao-Ling Huang; David D McPherson; Susan T Laing Journal: Ultrasound Med Biol Date: 2015-03-24 Impact factor: 2.998
Authors: Himanshu Shekhar; Kenneth B Bader; Shenwen Huang; Tao Peng; Shaoling Huang; David D McPherson; Christy K Holland Journal: Phys Med Biol Date: 2016-12-21 Impact factor: 3.609
Authors: Juefei Wu; Feng Xie; Tanmay Kumar; Jinjin Liu; John Lof; William Shi; E Carr Everbach; Thomas R Porter Journal: Ultrasound Med Biol Date: 2014-03-07 Impact factor: 2.998
Authors: Vishal Saxena; Carmen Gacchina Johnson; Ayele H Negussie; Karun V Sharma; Matthew R Dreher; Bradford J Wood Journal: Int J Hyperthermia Date: 2015-03-13 Impact factor: 3.914
Authors: Madhuvanthi A Kandadai; Prithviraj Mukherjee; Himanshu Shekhar; George J Shaw; Ian Papautsky; Christy K Holland Journal: Biomed Microdevices Date: 2016-06 Impact factor: 2.838